SecBot SecBot
8-K ·Filed Nov 12, 2026

ZBH

ZIMMER BIOMET HOLDINGS, INC.
NEUTRAL
Impact 3/10
Horizonweeks Processed4d 11h ago SEC0001193125-26-458323
8-K material event: Items 1.01
Actionable Insight • Neutral

The refinancing addresses upcoming maturities (EUR 500M Dec 2026 and $600M Feb 2027) and extends the company's debt maturity profile. Monitor the Q4 2026 earnings for updated leverage ratios and any acquisition announcements that may utilize the remaining proceeds.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$103.21
T+0 close · Nov 12, 2026 · via day close
Latest settled
−1.74%
T+1 · $101.41
Vs SPY
+0.17%
α at T+1
Next horizon
T+5
in 3d
  1. T+0 · Nov 13 $103.21entry
  2. T+1 · 21h ago −1.74%α +0.17% · $101.41
  3. T+5 · in 3d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Zimmer Biomet completed two concurrent debt offerings on November 12, 2026: EUR 500 million of 4.375% notes due 2033 and $500 million of 5.850% notes due 2036, with combined net proceeds of approximately $1.05 billion. The proceeds are earmarked for general corporate purposes including refinancing near-term maturities (EUR 500M 2.425% notes due Dec 2026 and/or $600M 4.700% notes due Feb 2027), share repurchases, and acquisitions. This is a routine debt refinancing and capital management move, not a distressed raise.

Key Facts

  • EUR 500 million 4.375% notes due 2033 issued at 99.594% of par, net proceeds ~EUR 496.4M (~$556.9M)
  • $500 million 5.850% notes due 2036 issued at 99.343% of par, net proceeds ~$495.1M
  • Both offerings closed on November 12, 2026, with combined net proceeds of approximately $1.05 billion
  • Proceeds to be used for general corporate purposes including potential repayment of EUR 500M 2.425% notes due Dec 2026 and/or $600M 4.700% notes due Feb 2027, share repurchases, and acquisitions
  • Neither offering was contingent on the other; both were priced on November 5, 2026
  • Company reported Q3 2026 results with modest revenue growth and raised full-year guidance five days prior to pricing

Financial Impact

Combined net proceeds of approximately $1.05 billion from two debt offerings, primarily for refinancing near-term maturities and general corporate purposes

debtinterest expenseleverage

Risk Factors

  • Increased total debt outstanding by approximately $1.05 billion, though partially offset by repayment of maturing notes
  • Higher blended interest cost: new notes carry 4.375% and 5.850% coupons vs. maturing notes at 2.425% and 4.700%

Market Snapshot

Exchange
NYSE
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
32% bullish (31 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-458323
Document: d118853dex42.htm0001193125-26-458323
Document: d118853dex12.htm0001193125-26-458323

Track record

17 reports on ZBH

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +8.74% at T+60 after the Apr 28, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 12, 20264d ago 8-K Neutral 3/10 Viewing Entry $103.21 Now $101.41 −1.74% settles Nov 20
  2. Nov 9, 20267d ago 424B5 Neutral 3/10 Entry $107.32 Now $101.41 −5.51% settles Nov 17
  3. Nov 9, 20267d ago 424B5 Neutral 3/10 Entry $107.32 Now $101.41 −5.51% settles Nov 17
  4. Nov 5, 202611d ago 424B5 Neutral 3/10 Entry $106.85 to $104.56 Now $101.41 −5.09% ▼ −2.14% −5.43% vs SPY
  5. Nov 5, 202611d ago 424B5 Neutral 2/10 Entry $106.85 to $104.56 Now $101.41 −5.09% ▼ −2.14% −5.43% vs SPY
  6. Nov 4, 202612d ago 8-K Neutral 5/10 Entry $110.15 to $107.47 Now $101.41 −7.93% ▼ −2.43% −1.52% vs SPY
  7. Oct 26, 202621d ago Institutional Cluster Bearish 4/10 Entry $97.44 to $94.52 Now $101.41 −4.07% ▲ +3.00% +1.74% vs SPY
  8. Oct 21, 202627d ago Court Ruling Bearish 6/10 Entry $98.81 to $97.47 Now $101.41 −2.63% ▲ +1.36% +2.06% vs SPY
  9. Sep 15, 20268w ago Insider Cluster Neutral 3/10 Entry $96.53 to $90.64 Now $101.41 +5.06% ▼ −6.10% −8.17% vs SPY
  10. Sep 2, 202610w ago Court Ruling Neutral 2/10 Entry $98.66 to $93.24 Now $101.41 +2.79% ▼ −5.49% −4.34% vs SPY
Showing 10 of 17

US Market Status

Market Closed · Opens in 5h 50m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026